SCHEMBL3379115

SCHEMBL3379115

CC(Cc1ccccc1)NBr

nearest known ligand 0.65

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ SIGMAR1 Q99720 10/20 0.65
▸ TAAR1 Q96RJ0 5/20 0.65
▸ SLC18A2 Q05940 1/20 0.65
▸ MEN1 O00255 1/20 0.57
▸ KMT2A Q03164 1/20 0.57
▸ NPC1 O15118 1/20 0.57
▸ RAB9A P51151 1/20 0.57
▸ CYP1A2 P05177 1/20 0.55
▸ CYP3A4 P08684 1/20 0.55
▸ CYP2D6 P10635 1/20 0.55
▸ TSHR P16473 1/20 0.55
▸ MAOA P21397 1/20 0.52
▸ SLC6A2 P23975 1/20 0.52
▸ SLC6A4 P31645 1/20 0.52
▸ SLC6A3 Q01959 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3379120 1.00 SIGMAR1 (0.65) SIGMAR1TAAR1SLC18A2MEN1KMT2A
SCHEMBL30624762 0.81 SIGMAR1 (0.71) SIGMAR1TAAR1SLC18A2MEN1KMT2A
SCHEMBL21243273 0.81 SIGMAR1 (0.73) SIGMAR1TAAR1SLC18A2MEN1KMT2A
Methamphetamine SCHEMBL20211416 0.79 SIGMAR1 (1.00) SIGMAR1TAAR1SLC18A2MEN1KMT2A
Methamphetamine SCHEMBL15094315 0.79 SIGMAR1 (1.00) SIGMAR1TAAR1SLC18A2MEN1KMT2A
SCHEMBL2828912 0.79 SIGMAR1 (0.68) SIGMAR1TAAR1SLC18A2MEN1KMT2A
Methamphetamine SCHEMBL13747483 0.79 SIGMAR1 (1.00) SIGMAR1TAAR1SLC18A2MEN1KMT2A
Methamphetamine SCHEMBL42615 0.79 SIGMAR1 (1.00) SIGMAR1TAAR1SLC18A2MEN1KMT2A
Levmetamfetamine SCHEMBL727412 0.79 SIGMAR1 (1.00) SIGMAR1TAAR1SLC18A2MEN1KMT2A
Methamphetamine SCHEMBL4781849 0.79 SIGMAR1 (1.00) SIGMAR1TAAR1SLC18A2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010017405-A1 METHODS AND COMPOSITIONS FOR THE TREATMENT OF PAIN HELLER ADAM (US) 2010-02-11 — — WO claimed
EP-4304576-A1 COMPOSITIONS COMPRISING ENZYME-CLEAVABLE PRODRUGS AND CONTROLLED RELEASE NAFAMOSTAT AND METHODS OF USE THEREOF Ensysce Biosciences, Inc. (US) 2024-01-17 — — EP disclosed
CN-114588124-B Delayed release pharmaceutical composition 江苏恒瑞医药股份有限公司 2023-10-20 — — CN disclosed
WO-2023107715-A1 SPECIALIZED COMBINATIONS FOR MENTAL DISORDERS OR MENTAL ENHANCEMENT TACTOGEN INC (US) 2023-06-15 — — WO disclosed
WO-2022192197-A1 COMPOSITIONS COMPRISING ENZYME-CLEAVABLE PRODRUGS AND CONTROLLED RELEASE NAFAMOSTAT AND METHODS OF USE THEREOF Ensysce Biosciences Inc. (US) 2022-09-15 — — WO disclosed
US-9869657-B2 Ion sensitive device and method of fabrication ELEMENTAL SENSOR LLC (US) 2018-01-16 — — US disclosed
US-20140348707-A1 ION SENSITIVE DEVICE AND METHOD OF FABRICATION ELEMENTAL SENSOR LLC 2014-11-27 — — US disclosed
WO-2010017405-A1 METHODS AND COMPOSITIONS FOR THE TREATMENT OF PAIN HELLER ADAM (US) 2010-02-11 — — WO disclosed
US-6829540-B1 Data processing, drug screening using immobilized artificial membrane chromatographic substrates in high pressure liquid chromatographic systems using aqueous mobile phases PURDUE RESEARCH FOUNDATION 2004-12-07 — — US disclosed
Send feedback